Skip to main content
Top
Published in: Clinical Rheumatology 1/2007

01-01-2007 | Original Article

Two cases with pachydermoperiostosis and discussion of tamoxifen citrate treatment for arthralgia

Authors: Ay?enur Okten, Ilke Mungan, Mukaddes Kalyoncu, Zerrin Orbak

Published in: Clinical Rheumatology | Issue 1/2007

Login to get access

Abstract

Idiopathic hypertrophic osteoarthropathy is a rare syndrome, characterized by clubbing, progressive enlargement of the joints, coarse facial features suggesting acromegaly, palmoplantar hyperhidrosis, fibrous covering at the ends of long bones (periostosis), and acro-osteolysis. It is a self-limiting condition but arthralgia may be as severe as limiting social life and activity, and it is the main complaint to be treated. We report on two siblings with pachydermoperiostosis (PDP), one of whom had arthralgia. Although several drugs have been used, we used tamoxifen for his arthralgia and his complaint disappeared. To the best of our knowledge, this is the second case treated by tamoxifen reported in the literature.
Literature
1.
go back to reference Matsui Y, Nishii Y, Maeda M, Okada N, Yoshikawa K (1991) PDP—report of a case and review of 121 Japanese cases. Nippon Hifuka Gakkai Zasshi 101:461–467 PubMed Matsui Y, Nishii Y, Maeda M, Okada N, Yoshikawa K (1991) PDP—report of a case and review of 121 Japanese cases. Nippon Hifuka Gakkai Zasshi 101:461–467 PubMed
2.
go back to reference Jajic Z, Jajic I, Nemcic T (2001) Primary hypertrophic osteoarthropathy. Clinical, radiologic, and scintigraphic characteristics. Arch Med Res 32:136–142CrossRefPubMed Jajic Z, Jajic I, Nemcic T (2001) Primary hypertrophic osteoarthropathy. Clinical, radiologic, and scintigraphic characteristics. Arch Med Res 32:136–142CrossRefPubMed
3.
go back to reference Matucci-Cerinic M, Lotti T, Jajic I, Pignone A, Bussani C, Cagnoni M (1991) The clinical spectrum of pachydermoperiostosis (primary hypertrophic osteoarthropathy). Medicine 70:208–214PubMedCrossRef Matucci-Cerinic M, Lotti T, Jajic I, Pignone A, Bussani C, Cagnoni M (1991) The clinical spectrum of pachydermoperiostosis (primary hypertrophic osteoarthropathy). Medicine 70:208–214PubMedCrossRef
4.
go back to reference Fischer DS, Singer DH, Felman SM (1964) Clubbing: a review with emphasis on hereditary acropathy. Medicine 43:459–479PubMedCrossRef Fischer DS, Singer DH, Felman SM (1964) Clubbing: a review with emphasis on hereditary acropathy. Medicine 43:459–479PubMedCrossRef
5.
go back to reference Rimoin DL (1965) Pachydermoperiostosis (idiopathic clubbing and periostosis). Genetic and physiological considerations. N Engl J Med 272:923–931PubMedCrossRef Rimoin DL (1965) Pachydermoperiostosis (idiopathic clubbing and periostosis). Genetic and physiological considerations. N Engl J Med 272:923–931PubMedCrossRef
6.
go back to reference Pineda C, Martinez Lavin M (1990) The spectrum of soft tissue and skeletal abnormalities of hypertrophic osteoarthropathy. J Rheumatol 17:626–632PubMed Pineda C, Martinez Lavin M (1990) The spectrum of soft tissue and skeletal abnormalities of hypertrophic osteoarthropathy. J Rheumatol 17:626–632PubMed
7.
go back to reference Pineda C (1992) Diagnostic imaging in hypertrophic osteoarthropathy. Clin Exp Rheum 10 [Suppl 7]:27–33 Pineda C (1992) Diagnostic imaging in hypertrophic osteoarthropathy. Clin Exp Rheum 10 [Suppl 7]:27–33
8.
go back to reference Sinha GP, Curtis P, Haigh D, Lealman TG, Dodds W, Bennett CP (1997) Pachydermoperiostosis in childhood. Paediatr Rheumatol 36:1224–1227CrossRef Sinha GP, Curtis P, Haigh D, Lealman TG, Dodds W, Bennett CP (1997) Pachydermoperiostosis in childhood. Paediatr Rheumatol 36:1224–1227CrossRef
9.
go back to reference Ansell BM (1992) Hypertrophic osteoarthropathy in the paediatric age. Clin Exp Rheumatol 10 [Suppl 7]:15–18PubMed Ansell BM (1992) Hypertrophic osteoarthropathy in the paediatric age. Clin Exp Rheumatol 10 [Suppl 7]:15–18PubMed
10.
go back to reference Oikarinen A, Palatsi R, Kylmaniemi M, Keski-Oja J, Ristelli J, Kallioinen M (1994) PDP: analysis of the connective tissue abnormalities in one family. J Am Acad Dermatol 31:947–953 PubMedCrossRef Oikarinen A, Palatsi R, Kylmaniemi M, Keski-Oja J, Ristelli J, Kallioinen M (1994) PDP: analysis of the connective tissue abnormalities in one family. J Am Acad Dermatol 31:947–953 PubMedCrossRef
11.
go back to reference Matucci-Cerinic M, Sacerdoti L, Perrone C, Carossino A, Cagnoni ML, Jagic I et al (1992) Pachydermoperiostosis: in vitro evidence for abnormal fibroblast proliferations. Clin Exp Rheumatol 10 [Suppl 7]:57–60PubMed Matucci-Cerinic M, Sacerdoti L, Perrone C, Carossino A, Cagnoni ML, Jagic I et al (1992) Pachydermoperiostosis: in vitro evidence for abnormal fibroblast proliferations. Clin Exp Rheumatol 10 [Suppl 7]:57–60PubMed
12.
go back to reference Bianchi L, Lubrano C, Carrozzo AM, Iraci S, Tomassoli M, Spera G et al (1995) Pachydermoperiostosis: study of epidermal growth factor and steroid receptors. Br J Dermatol 132:128–133PubMedCrossRef Bianchi L, Lubrano C, Carrozzo AM, Iraci S, Tomassoli M, Spera G et al (1995) Pachydermoperiostosis: study of epidermal growth factor and steroid receptors. Br J Dermatol 132:128–133PubMedCrossRef
13.
go back to reference Maeda H, Kumagai K, Konnishi F, Katayamma Y, Hiyama K, Ishioka S, Yamakido M (2000) Successful treatment of arthralgia with tamoxifen citrate in a patient with pachydermoperiostosis. Rheumatology 39:1158–1159CrossRefPubMed Maeda H, Kumagai K, Konnishi F, Katayamma Y, Hiyama K, Ishioka S, Yamakido M (2000) Successful treatment of arthralgia with tamoxifen citrate in a patient with pachydermoperiostosis. Rheumatology 39:1158–1159CrossRefPubMed
Metadata
Title
Two cases with pachydermoperiostosis and discussion of tamoxifen citrate treatment for arthralgia
Authors
Ay?enur Okten
Ilke Mungan
Mukaddes Kalyoncu
Zerrin Orbak
Publication date
01-01-2007
Publisher
Springer-Verlag
Published in
Clinical Rheumatology / Issue 1/2007
Print ISSN: 0770-3198
Electronic ISSN: 1434-9949
DOI
https://doi.org/10.1007/s10067-005-1161-2

Other articles of this Issue 1/2007

Clinical Rheumatology 1/2007 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.